The prevalence of hypertension in type 2 diabetes patients is substantially greater than in nondiabetes population and is reported between 40 and 60%.
1
In the United Kingdom Prospective Diabetes Study (UKPDS) 40% of men and 53% of women were found to have BP over 160/95 mmHg.
2 Coexistence of diabetes and hypertension is particularly unfavourable as both conditions are significant risk factors for vascular injury. According to this report hypertension should be diagnosed if SBP is greater or equal to 140 mmHg and DBP to 90 mmHg. 1 We performed a study aiming at assessing BP in newly diagnosed diabetes mellitus patients, in whom hypertension had never been diagnosed.
The studied cohort consisted of randomly selected 967 adult individuals aged 435 years (mean age 62.1710.8 years), never diagnosed with either diabetes or hypertension any time before the study. This group was a part of a larger sample (n ¼ 2018) drawn from a local council registry as a part of a nationwide project aiming at assessing cardiovascular risk factors in the population. Full medical examination was performed in all patients. BP was measured with the use of mercury sphygmomanometer three times after 10 min rest, in 1 min intervals, with the average of three readings considered. As recommended, 4 four different cuff sizes were used: 12 Â 22 cm for arm circumference 22-26 cm, 16 Â 30 cm for arm circumference 27-34 cm, 16 Â 36 cm for arm circumference 35-44 cm, and 20 Â 42 cm for arm circumference 445 cm.
Fasting plasma glucose and lipids were measured using standard enzymatic methods. Oral glucose tolerance test (OGTT) with 75 g glucose was conducted in all subjects. The subjects in whom diabetes was diagnosed formed Group 1 (study group), while Group 2 comprised individuals without diabetes (controls). 4 ) , that is, SBP o120 and DBP o80 mmHg was found only in four (4%) persons with newly diagnosed diabetes (including one with BP 90/60 mmHg), which means that 96% of Group 1 subjects had BP 4120/80 mmHg and thus had either prehypertension or hypertension. In nondiabetes group normal BP was noted in 215 subjects (25%), leaving three out of four persons with pre-or hypertension (Po0.0001).
SBP4130 mmHg was found in 84 (88%) diabetes subjects and in 453 (52%) nondiabetes subjects (Po0.0001). Hypertension according to JNC 7 report 1 (BP4140/90) was found in 65 (68%) persons with diabetes and in 351 (40%) nondiabetes individuals (Po0.001).
In the studied group prevalence of newly diagnosed diabetes was high (almost 10%), however. many studies confirm rising number of diabetes worldwide, especially in older age groups. 5 Similarly, the number of people with hypertension in the United States increased by 30% between 1988 and 1994 and 1999-2000; and at present 31.3% Americans is hypertensive. 6 We found that almost all (96%) of the subjects who were newly diagnosed with diabetes had abnormally elevated BP: 68% had hypertension and 28% prehypertension. Incidence of hypertension was similar to those reported in UKPDS or other large scale studies, however, with added prehypertension figures the overall incidence of elevated BP was strikingly high.
In diabetes subjects only SBP was higher than in nondiabetes individuals, while diastolic values were similar. This difference may be partly explained by diabetes patients being older than nondiabetes persons, however, 2 years' difference in age cannot be the only responsible factor for over 11 mmHg SBP difference. 7 Common presence of such metabolic syndrome elements as abdominal obesity, high plasma triglyceride and low HDL cholesterol in diabetes patients may offer a plausible explanation. These abnormalities are associated with insulin resistance, which may contribute to the development of hypertension. 8 Another explanation for high incidence of increased BP among diabetic patients is the formation of advanced glycation endproducts (AGEs) early in the course of glucose intolerance. AGEs are responsible for arterial stiffening leading to the increase in SBP and pulse pressure. 9 Up to onethird of adults with newly diagnosed diabetes mellitus already have chronic kidney disease, 10 which even in subclinical stage may lead to BP elevation. High salt intake, low level of physical exercise and high alcohol consumption may also play causative role in SBP elevation noted in newly diagnosed diabetic patients. 11 The implications of our findings are two-fold. Firstly, it seems that all but few newly diagnosed diabetes patients require antihypertensive treatment. According to JNC 7 guidelines prehypertension in subjects with diabetes is a 'compelling indication' for drug therapy.
1 Diagnosis of diabetes therefore should equal the necessity of antihypertensive treatment almost in every patient. As majority of hypertension patients do not reach the target BP values, 7 beginning the treatment as early as at the time of diabetes diagnosis should facilitate achieving this goal.
Secondly, a high rate of abnormal BP in diabetes patients is apparently related to the features of metabolic syndrome. 8 Weight reduction and increase in physical exercise have significant beneficial effect on BP. 12 Although the need for antihypertensive agents in newly diagnosed diabetes patients is apparent, lifestyle intervention is equally important as it helps control multiple metabolic abnormalities.
In conclusion, we found that almost every subject with newly diagnosed diabetes meets JNC-7 defined criteria of prehypertension or hypertension. Although antihypertensive drug therapy is recommended in this group of patients, lifestyle intervention targeting obesity and lipid disorders should be equally essential. 
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